All Updates

All Updates

icon
Filter
Industry news
Brevel opens commercial plant for production of microalgae protein powder
Plant-based Meat
Jun 4, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Jun 20, 2024
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Jun 20, 2024
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Jun 20, 2024
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Jun 20, 2024
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Jun 20, 2024
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Jun 20, 2024
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Jun 20, 2024
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Jun 20, 2024
Plant-based Meat

Plant-based Meat

Jun 4, 2024

Brevel opens commercial plant for production of microalgae protein powder

Industry news

  • Brevel, an Israeli microalgae-based ingredients startup, has inaugurated its first commercial plant in Israel to manufacture its new patented microalgae protein powder. The first products from this facility are slated for rollout in Q1 2025.

  • The new 27,000 sq feet (2,500 sq m) facility will house the company’s headquarters, an R&D center, and a large-scale commercial manufacturing area. It will also feature multiple bioreactors of varying capacities, including its first 5,000-liter bioreactor, enabling it to produce hundreds of tons of microalgae protein annually.

  • Brevel’s flagship microalgae protein is extracted from chlorella microalgae utilizing proprietary technology that combines fermentation and photosynthesis in indoor, fully automated reactors. According to the company, this ingredient is comparable in price and functionality to commonly used soy and pea proteins.

  • Analyst QuickTake: Brevel’s USD 18.5 million in a seed funding round facilitated the construction of this plant, which was intended for further development of its protein and expansion of operations. This facility is the first of two planned constructions, with the second facility slate for 2025, expected to have a total capacity of 900,000 l.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.